Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 78
Filter
1.
ACS Synth Biol ; 10(3): 620-631, 2021 03 19.
Article in English | MEDLINE | ID: mdl-33719397

ABSTRACT

l-Theanine, as an active component of the leaves of the tea plant, possesses many health benefits and broad applications. Chemical synthesis of l-theanine is possible; however, this method generates chiral compounds and needs further isolation of the pure l-isoform. Heterologous biosynthesis is an alternative strategy, but one main limitation is the toxicity of the substrate ethylamine on microbial host cells. In this study, we introduced a cell-free protein synthesis (CFPS) system for l-theanine production. The CFPS expressed l-theanine synthetase 2 from Camellia sinensis (CsTS2) could produce l-theanine at a concentration of 11.31 µM after 32 h of the synthesis reaction. In addition, three isozymes from microorganisms were expressed in CFPS for l-theanine biosynthesis. The γ-glutamylcysteine synthetase from Escherichia coli could produce l-theanine at the highest concentration of 302.96 µM after 24 h of reaction. Furthermore, CFPS was used to validate a hypothetical two-step l-theanine biosynthetic pathway consisting of the l-alanine decarboxylase from C. sinensis (CsAD) and multiple l-theanine synthases. Among them, the combination of CsAD and the l-glutamine synthetase from Pseudomonas taetrolens (PtGS) could synthesize l-theanine at the highest concentration of 13.42 µM. Then, we constructed an engineered E. coli strain overexpressed CsAD and PtGS to further confirm the l-theanine biosynthesis ability in living cells. This engineered E. coli strain could convert l-alanine and l-glutamate in the medium to l-theanine at a concentration of 3.82 mM after 72 h of fermentation. Taken together, these results demonstrated that the CFPS system can be used to produce the l-theanine through the two-step l-theanine biosynthesis pathway, indicating the potential application of CFPS for the biosynthesis of other active compounds.


Subject(s)
Cell-Free System , Glutamates/biosynthesis , Amide Synthases/classification , Amide Synthases/genetics , Bacterial Proteins/genetics , Camellia sinensis/enzymology , Camellia sinensis/genetics , Escherichia coli/enzymology , Escherichia coli/genetics , Escherichia coli Proteins/genetics , Glutamate-Ammonia Ligase/genetics , Glutamate-Cysteine Ligase/genetics , Isoenzymes/classification , Isoenzymes/economics , Phylogeny , Plant Proteins/classification , Plant Proteins/genetics , Pseudomonas/enzymology , Pseudomonas/genetics
2.
mBio ; 12(2)2021 03 23.
Article in English | MEDLINE | ID: mdl-33758090

ABSTRACT

Cobamides are cobalt-containing cyclic tetrapyrroles used by cells from all domains of life but only produced de novo by some bacteria and archaea. The "late steps" of the adenosylcobamide biosynthetic pathway are responsible for the assembly of the nucleotide loop and are required during de novo synthesis and precursor salvaging. These steps are characterized by activation of the corrin ring and lower ligand base, condensation of the activated precursors to adenosylcobamide phosphate, and removal of the phosphate, yielding a complete adenosylcobamide molecule. The condensation of the activated corrin ring and lower ligand base is performed by an integral membrane protein, cobamide (5' phosphate) synthase (CobS), and represents an important convergence of two pathways necessary for nucleotide loop assembly. Interestingly, membrane association of this penultimate step is conserved among all cobamide producers, yet the physiological relevance of this association is not known. Here, we present the purification and biochemical characterization of the CobS enzyme of the enterobacterium Salmonella enterica subsp. enterica serovar Typhimurium strain LT2, investigate its association with liposomes, and quantify the effect of the lipid bilayer on its enzymatic activity and substrate affinity. We report a purification scheme that yields pure CobS protein, allowing in vitro functional analysis. Additionally, we report a method for liposome reconstitution of CobS, allowing for physiologically relevant studies of this inner membrane protein in a phospholipid bilayer. In vitro and in vivo data reported here expand our understanding of CobS and the implications of membrane-associated adenosylcobamide biosynthesis.IMPORTANCESalmonella is a human pathogen of worldwide importance, and coenzyme B12 is critical for the pathogenic lifestyle of this bacterium. The importance of the work reported here lies on the improvements to the methodology used to isolate cobamide synthase, a polytopic integral membrane protein that catalyzes the penultimate step of coenzyme B12 biosynthesis. This advance is an important step in the analysis of the proposed multienzyme complex responsible for the assembly of the nucleotide loop during de novo coenzyme B12 biosynthesis and for the assimilation of incomplete corrinoids from the environment. We proposed that cobamide synthase is likely localized to the cell membrane of every coenzyme B12-producing bacterium and archaeum sequenced to date. The new knowledge of cobamide synthase advances our understanding of the functionality of the enzyme in the context of the lipid bilayer and sets the foundation for the functional-structural analysis of the aforementioned multienzyme complex.


Subject(s)
Amide Synthases/genetics , Bacterial Outer Membrane/metabolism , Cobamides/biosynthesis , Salmonella/enzymology , Salmonella/genetics , Amide Synthases/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biosynthetic Pathways , Liposomes/metabolism , Salmonella/metabolism
3.
Sci Rep ; 11(1): 4604, 2021 02 25.
Article in English | MEDLINE | ID: mdl-33633267

ABSTRACT

Rimklb is a mammalian homologue of the E. coli enzyme RimK, which catalyzes addition of glutamic acid to the ribosomal protein S6. To date, no previous studies have shown any physiological role for Rimklb in mammals. In this study, using Western blotting, we found that Rimklb is distributed and expressed in mouse testis and heart. Rimklb was subsequently localized to the testicular Leydig cells using immunohistochemistry with an anti-Rimklb antibody. We generated a Rimklb mutant mouse in which a three-base deletion results in deletion of Ala 29 and substitution of Leu 30 with Val, which we named the RimklbA29del, L30V mutant mouse. RimklbA29del, L30V mutant mice show a decrease in testicular size and weight, and in vitro fertilization demonstrates complete male infertility. Furthermore, we found that a key factor in the mammalian target of the rapamycin/ribosomal protein S6 transcriptional pathway is hyperphosphorylated in the seminiferous tubules of the mutant testis. We conclude that Rimklb has important roles that include spermatogenesis in seminiferous tubules. In summary, male RimklbA29del, L30V mice are infertile.


Subject(s)
Amide Synthases/genetics , Infertility, Male/genetics , Amino Acid Substitution/genetics , Animals , Blotting, Western , Male , Mice , Phosphorylation , Sperm Count , Spermatogenesis/genetics
4.
Plant Sci ; 298: 110546, 2020 Sep.
Article in English | MEDLINE | ID: mdl-32771159

ABSTRACT

l-Theanine, a non-proteinaceous amino acid abundantly present in tea (Camellia sinensis), contributes to the umami flavor of tea and has beneficial effects on human health. While key l-theanine biosynthetic genes have been well documented, their transcriptional regulation remains poorly understood. In this study, we determined the l-theanine contents in tea leaves of two cultivars at three developmental stages and investigated the expression patterns of the l-theanine biosynthetic genes CsGS1 and CsGS2. Additionally, we identified an R2R3-MYB transcription factor, CsMYB73, belonging to subgroup 22 of the R2R3-MYB family. CsMYB73 expression negatively correlated with l-theanine accumulation during leaf maturation. We found that CsMYB73, as a nuclear protein, binds to the promoter regions of CsGS1 and CsGS2 via MYB recognition sequences and represses the transcription of CsGS1 and CsGS2 in tobacco leaves. Collectively, our results demonstrate that CsMYB73 is a transcriptional repressor involved in l-theanine biosynthesis in tea plants. Our findings might contribute to future tea plant breeding strategies.


Subject(s)
Amide Synthases/genetics , Camellia sinensis/genetics , Glutamates/biosynthesis , Plant Proteins/genetics , Transcription Factors/genetics , Amide Synthases/metabolism , Amino Acid Sequence , Camellia sinensis/enzymology , Phylogeny , Plant Leaves/metabolism , Plant Proteins/chemistry , Plant Proteins/metabolism , Sequence Alignment , Transcription Factors/chemistry , Transcription Factors/metabolism
5.
J Gen Appl Microbiol ; 66(5): 265-272, 2020 Nov 30.
Article in English | MEDLINE | ID: mdl-32641635

ABSTRACT

The degradation pathways in microorganisms for piperidine, a secondary amine with various applications, are not yet fully understood, especially in non-Mycobacterium species. In this study, we have identified a piperidine-degrading isolate (KU43P) from a soil sample collected in a cultivation field in Osaka, Japan, and characterized its mechanisms of piperidine degradation, thereby furthering current understanding of the process. The genome of isolate KU43P consists of a 5,869,691-bp circular chromosome with 62.67% GC content and with 5,294 predicted protein-coding genes, 77 tRNA genes, and 22 rRNA genes. 16S rRNA gene sequence analysis and average nucleotide identity analysis suggest that the isolate is a novel species of the Pseudomonas putida group in the genus Pseudomonas. The genomic region encoding the piperidine degradation pathway, designated as the pip gene cluster, was identified using transposon mutagenesis and reverse transcription polymerase chain reaction. Deletion analyses of pipA, which encodes a glutamine synthetase (GS)-like protein, and pipBa, which encodes a cytochrome P450 monooxygenase, indicate that pipA and pipBa are involved in piperidine metabolism and suggest that pipA is involved in the first step of the piperidine metabolic pathway. Escherichia coli whole cells overexpressing PipA converted piperidine and glutamate to γ-glutamylpiperidide, and crude cell extract enzyme assays of PipA showed that this reaction requires ATP and Mg2+. These results clearly show that pipA encodes γ-glutamylpiperidide synthetase and that piperidine is first glutamylated and then hydroxylated in the piperidine degradation pathway of Pseudomonas sp. strain KU43P. This study has filled a void in the general knowledge of the microbial degradation of amine compounds.


Subject(s)
Piperidines/metabolism , Pseudomonas/metabolism , Amide Synthases/genetics , Amide Synthases/metabolism , Bacterial Proteins/genetics , Bacterial Proteins/metabolism , Biodegradation, Environmental , Cytochrome P-450 Enzyme System/genetics , Cytochrome P-450 Enzyme System/metabolism , Escherichia coli/genetics , Escherichia coli/metabolism , Genome, Bacterial/genetics , Metabolic Networks and Pathways , Multigene Family , Mutation , Phylogeny , Pseudomonas/classification , Pseudomonas/genetics , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Transcription, Genetic
6.
Int J Biol Macromol ; 153: 817-835, 2020 Jun 15.
Article in English | MEDLINE | ID: mdl-32165202

ABSTRACT

The genome of Mycobacterium tuberculosis encode for several hypothetical proteins that needed to be characterized. Rv2037c, a hypothetical protein, was 25 and 4 folds upregulated under acidic and nutritive stress, respectively in M. tuberculosis H37Ra. The protein demonstrated lipolytic activity with pNP-decanoate with optimum pH 8.0 and temperature 40 °C. In addition, the protein demonstrated phospholipase activity. To understand the effect of rv2037c on mycobacterium physiology, the gene was cloned and expressed in M. smegmatis. The protein was found in membrane and extracellular fraction. The expression of rv2037c in M. smegmatis (MS_Rv2037c) altered colony morphology and cell surface features like enhanced biofilm and pellicle formation. MS_Rv2037c decreased cell-wall permeability, enhanced TDM content, resistance against various stresses and antibiotics. MS_Rv2037c demonstrated better infection and intracellular survival capability in infected THP-1 macrophage. Macrophages treated with Rv2037c demonstrated irregular cell membrane. Mice infected with MS_Rv2037c had higher bacterial load in lung, liver and spleen compared to control. Rv2037c induced the production of pro-inflammatory cytokines TNFα and IL12, suggesting its role in immune-modulation. Recombinant protein also generated humoral response in EPTB and MDR-TB patients. The results pointed towards the crucial role of this enzyme in cell-wall modulation, infection and intracellular survival of mycobacterium.


Subject(s)
Amide Synthases/metabolism , Bacterial Proteins/metabolism , Biofilms/growth & development , Cell Wall/enzymology , Microbial Viability , Mycobacterium tuberculosis/physiology , Phospholipases/metabolism , Amide Synthases/genetics , Bacterial Proteins/genetics , Cell Wall/genetics , Mycobacterium smegmatis/physiology , Phospholipases/genetics
7.
Appl Microbiol Biotechnol ; 104(8): 3417-3431, 2020 Apr.
Article in English | MEDLINE | ID: mdl-32103318

ABSTRACT

γ-Glutamylcysteine synthetase (γ-GCS) from Escherichia coli, which catalyzes the formation of L-glutamylcysteine from L-glutamic acid and L-cysteine, was engineered into an L-theanine synthase using L-glutamic acid and ethylamine as substrates. A high-throughput screening method using a 96-well plate was developed to evaluate the L-theanine synthesis reaction. Both site-saturation mutagenesis and random mutagenesis were applied. After three rounds of directed evolution, 13B6, the best-performing mutant enzyme, exhibited 14.6- and 17.0-fold improvements in L-theanine production and catalytic efficiency for ethylamine, respectively, compared with the wild-type enzyme. In addition, the specific activity of 13B6 for the original substrate, L-cysteine, decreased to approximately 14.6% of that of the wild-type enzyme. Thus, the γ-GCS enzyme was successfully switched to a specific L-theanine synthase by directed evolution. Furthermore, an ATP-regeneration system was introduced based on polyphosphate kinases catalyzing the transfer of phosphates from polyphosphate to ADP, thus lowering the level of ATP consumption and the cost of L-theanine synthesis. The final L-theanine production by mutant 13B6 reached 30.4 ± 0.3 g/L in 2 h, with a conversion rate of 87.1%, which has great potential for industrial applications.


Subject(s)
Amide Synthases/metabolism , Escherichia coli/enzymology , Glutamate-Cysteine Ligase/metabolism , Glutamates/biosynthesis , Adenosine Triphosphate/metabolism , Amide Synthases/genetics , Catalysis , Directed Molecular Evolution , Escherichia coli/genetics , Ethylamines/metabolism , Glutamate-Cysteine Ligase/genetics , Glutamic Acid/metabolism , High-Throughput Screening Assays , Industrial Microbiology , Protein Engineering
8.
Nat Commun ; 11(1): 16, 2020 01 07.
Article in English | MEDLINE | ID: mdl-31911602

ABSTRACT

NAD+ synthetase is an essential enzyme of de novo and recycling pathways of NAD+ biosynthesis in Mycobacterium tuberculosis but not in humans. This bifunctional enzyme couples the NAD+ synthetase and glutaminase activities through an ammonia tunnel but free ammonia is also a substrate. Here we show that the Homo sapiens NAD+ synthetase (hsNadE) lacks substrate specificity for glutamine over ammonia and displays a modest activation of the glutaminase domain compared to tbNadE. We report the crystal structures of hsNadE and NAD+ synthetase from M. tuberculosis (tbNadE) with synthetase intermediate analogues. Based on the observed exclusive arrangements of the domains and of the intra- or inter-subunit tunnels we propose a model for the inter-domain communication mechanism for the regulation of glutamine-dependent activity and NH3 transport. The structural and mechanistic comparison herein reported between hsNadE and tbNadE provides also a starting point for future efforts in the development of anti-TB drugs.


Subject(s)
Amide Synthases/metabolism , Ammonia/metabolism , Bacterial Proteins/metabolism , Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor/metabolism , Mycobacterium tuberculosis/enzymology , Amide Synthases/chemistry , Amide Synthases/genetics , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor/chemistry , Carbon-Nitrogen Ligases with Glutamine as Amide-N-Donor/genetics , Catalytic Domain , Glutaminase/chemistry , Glutaminase/genetics , Glutaminase/metabolism , Glutamine/metabolism , Humans , Mycobacterium tuberculosis/chemistry , Mycobacterium tuberculosis/genetics , Mycobacterium tuberculosis/metabolism , NAD/metabolism , Substrate Specificity
9.
Chem Commun (Camb) ; 55(98): 14840-14843, 2019 Dec 05.
Article in English | MEDLINE | ID: mdl-31768510

ABSTRACT

XimA is a unique amide synthetase that belongs to the ANL superfamily of adenylating enzymes, but with a special structural fold. In order to improve the enzyme promiscuity, we engineered XimA by site-directed mutagenesis at a specific position based on our theoretical model of XimA. Thus, we were able to produce diverse benzopyran derivatives with up to 15 different l-form and d-form amino acid substitutions, catalyzed by several XimA variants. Molecular docking and molecular dynamics simulations conducted for various XimA systems provide further structural insights into the substitution effects of the phenylalanine-201 as an active site residue on protein dynamics and enzyme catalysis.


Subject(s)
Amide Synthases/metabolism , Threonine/analogs & derivatives , Amide Synthases/genetics , Benzopyrans/chemistry , Benzopyrans/metabolism , Kinetics , Mutagenesis, Site-Directed , Peptide Synthases/metabolism , Protein Engineering , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Streptomyces/chemistry , Streptomyces/metabolism , Substrate Specificity , Threonine/biosynthesis , Threonine/chemistry
10.
Gene ; 710: 279-290, 2019 Aug 20.
Article in English | MEDLINE | ID: mdl-31200083

ABSTRACT

Plants are frequently exposed to variable environmental stresses that adversely affect plant growth, development and agricultural production. In this study, a trypanothione synthetase gene from Trypanosoma cruzi, TcTryS, was chemically synthesized and its roles in tolerance to multiple abiotic stresses were functionally characterized by generating transgenic rice overexpressing TcTryS. Overexpression of TcTryS in rice endows transgenic plants with hypersensitivity to ABA, hyposensitivity to NaCl- and mannitol-induced osmotic stress at the seed germination stage. TcTryS overexpression results in enhanced tolerance to drought, salt, cadmium, and 2,4,6-trichlorophenol stresses in transgenic rice, simultaneously supported by improved physiological traits. The TcTryS-overexpression plants also accumulated greater amounts of proline, less malondialdehyde and more transcripts of stress-related genes than wild-type plants under drought and salt stress conditions. In addition, TcTryS might play a positive role in maintaining chlorophyll content under 2,4,6-trichlorophenol stress. Histochemical staining assay showed that TcTryS renders transgenic plants better ROS-scavenging capability. All of these results suggest that TcTryS could function as a key regulator in modulation of abiotic stress tolerance in plant, and may have applications in the engineering of economically important crops.


Subject(s)
Amide Synthases/genetics , Amide Synthases/metabolism , Oryza/genetics , Stress, Physiological , Trypanosoma cruzi/enzymology , Abscisic Acid/pharmacology , Cadmium/toxicity , Droughts , Gene Expression Regulation, Plant , Oryza/growth & development , Plants, Genetically Modified/growth & development , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Salt Tolerance , Trypanosoma cruzi/genetics , Up-Regulation
11.
Redox Biol ; 26: 101231, 2019 09.
Article in English | MEDLINE | ID: mdl-31203195

ABSTRACT

Trypanothione (T(SH)2) is the main antioxidant metabolite for peroxide reduction in Trypanosoma cruzi; therefore, its metabolism has attracted attention for therapeutic intervention against Chagas disease. To validate drug targets within the T(SH)2 metabolism, the strategies and methods of Metabolic Control Analysis and kinetic modeling of the metabolic pathway were used here, to identify the steps that mainly control the pathway fluxes and which could be appropriate sites for therapeutic intervention. For that purpose, gamma-glutamylcysteine synthetase (γECS), trypanothione synthetase (TryS), trypanothione reductase (TryR) and the tryparedoxin cytosolic isoform 1 (TXN1) were separately overexpressed to different levels in T. cruzi epimastigotes and their degrees of control on the pathway flux as well as their effect on drug resistance and infectivity determined. Both experimental in vivo as well as in silico analyses indicated that γECS and TryS control T(SH)2 synthesis by 60-74% and 15-31%, respectively. γECS overexpression prompted up to a 3.5-fold increase in T(SH)2 concentration, whereas TryS overexpression did not render an increase in T(SH)2 levels as a consequence of high T(SH)2 degradation. The peroxide reduction flux was controlled for 64-73% by TXN1, 17-20% by TXNPx and 11-16% by TryR. TXN1 and TryR overexpression increased H2O2 resistance, whereas TXN1 overexpression increased resistance to the benznidazole plus buthionine sulfoximine combination. γECS overexpression led to an increase in infectivity capacity whereas that of TXN increased trypomastigote bursting. The present data suggested that inhibition of high controlling enzymes such as γECS and TXN1 in the T(SH)2 antioxidant pathway may compromise the parasite's viability and infectivity.


Subject(s)
Antioxidants/metabolism , Glutamate-Cysteine Ligase/genetics , Glutathione/analogs & derivatives , Protozoan Proteins/genetics , Spermidine/analogs & derivatives , Thioredoxins/genetics , Trypanosoma cruzi/drug effects , Amide Synthases/genetics , Amide Synthases/metabolism , Buthionine Sulfoximine/pharmacology , Cell Line , Drug Combinations , Drug Resistance/genetics , Fibroblasts/parasitology , Gene Expression Regulation , Glutamate-Cysteine Ligase/metabolism , Glutathione/antagonists & inhibitors , Glutathione/biosynthesis , Humans , Hydrogen Peroxide/pharmacology , NADH, NADPH Oxidoreductases/genetics , NADH, NADPH Oxidoreductases/metabolism , Nitroimidazoles/pharmacology , Oxidation-Reduction , Oxidative Stress , Peroxidases/genetics , Peroxidases/metabolism , Protozoan Proteins/metabolism , Signal Transduction , Spermidine/antagonists & inhibitors , Spermidine/biosynthesis , Thioredoxins/metabolism , Trypanocidal Agents/pharmacology , Trypanosoma cruzi/enzymology , Trypanosoma cruzi/genetics
12.
Free Radic Biol Med ; 130: 23-34, 2019 01.
Article in English | MEDLINE | ID: mdl-30359758

ABSTRACT

BACKGROUND: Chagas cardiomyopathy, caused by Trypanosoma cruzi infection, continues to be a neglected illness, and has a major impact on global health. The parasite undergoes several stages of morphological and biochemical changes during its life cycle, and utilizes an elaborated antioxidant network to overcome the oxidants barrier and establish infection in vector and mammalian hosts. Trypanothione synthetase (TryS) catalyzes the biosynthesis of glutathione-spermidine adduct trypanothione (T(SH)2) that is the principal intracellular thiol-redox metabolite in trypanosomatids. METHODS AND RESULTS: We utilized genetic overexpression (TryShi) and pharmacological inhibition approaches to examine the role of TryS in T. cruzi proliferation, tolerance to oxidative stress and resistance to anti-protozoal drugs. Our data showed the expression and activity of TryS was increased in all morphological stages of TryShi (vs. control) parasites. In comparison to controls, the TryShi epimastigotes (insect stage) recorded shorter doubling time, and both epimastigotes and infective trypomastigotes of TryShi exhibited 36-71% higher resistance to H2O2 (50-1000 µM) and heavy metal (1-500 µM) toxicity. Treatment with TryS inhibitors (5-30 µM) abolished the proliferation and survival advantages against H2O2 pressure in a dose-dependent manner in both TryShi and control parasites. Further, epimastigote and trypomastigote forms of TryShi (vs. control) T. cruzi tolerated higher doses of benznidazole and nifurtimox, the drugs currently administered for acute Chagas disease treatment. CONCLUSIONS: TryS is essential for proliferation and survival of T. cruzi under normal and oxidant stress conditions, and provides an advantage to the parasite to develop resistance against currently used anti-trypanosomal drugs. TryS indispensability has been chemically validated with inhibitors that may be useful for drug combination therapy against Chagas disease.


Subject(s)
Amide Synthases/metabolism , Antioxidants/metabolism , Chagas Cardiomyopathy/parasitology , Protozoan Proteins/metabolism , Trypanosoma cruzi/physiology , Amide Synthases/genetics , Animals , Antiprotozoal Agents/therapeutic use , Cell Proliferation , Cells, Cultured , Chagas Cardiomyopathy/drug therapy , Drug Resistance , Humans , Oxidation-Reduction , Oxidative Stress , Protozoan Proteins/genetics , Transgenes/genetics
13.
Pediatr Obes ; 13(7): 433-441, 2018 07.
Article in English | MEDLINE | ID: mdl-29761652

ABSTRACT

BACKGROUND: Vitamin D deficiency has been associated with non-alcoholic fatty liver disease (NAFLD). However, the role of polymorphisms determining vitamin D status remains unknown. OBJECTIVES: The objectives of this study were to determine in UK children with biopsy-proven NAFLD (i) their vitamin D status throughout a 12-month period and (ii) interactions between key vitamin D-related genetic variants (nicotinamide adenine dinucleotide synthase-1/dehydrocholesterol reductase-7, vitamin D receptor, group-specific component, CYP2R1) and disease severity. METHODS: In 103 paediatric patients with NAFLD, serum 25-hydroxyvitamin D (25OHD) levels and genotypes were determined contemporaneously to liver biopsy and examined in relation to NAFLD activity score and fibrosis stage. RESULTS: Only 19.2% of children had adequate vitamin D status; most had mean 25OHD levels considered deficient (<25 nmol·L-1 , 25.5%) or insufficient (<50 nmol·L-1 , 55.3%). Patients had significantly lower 25OHD levels in winter months (95% CI: 22.7-31.2 nmol·L-1 ) when compared with spring (30.5-42.1 nmol·L-1 ; P = 0.0089), summer (36.3-47.2 nmol·L-1 ; P < 0.0001) and autumn (34.2-47.5 nmol·L-1 ; P = 0.0003). Polymorphisms in the nicotinamide adenine dinucleotide synthase-1/dehydrocholesterol reductase-7 (rs3829251, rs12785878) and vitamin D receptor (rs2228570) genes were independently associated with increased steatosis; while a group-specific component variant (rs4588) was associated with increased inflammation in liver biopsies. CONCLUSIONS: Children with NAFLD in the UK have particularly low winter vitamin D status, with vitamin D insufficiency prevalent throughout the year. Polymorphisms in the vitamin D metabolic pathway are associated with histological severity of paediatric NAFLD.


Subject(s)
Non-alcoholic Fatty Liver Disease/genetics , Polymorphism, Genetic , Vitamin D/analogs & derivatives , Amide Synthases/genetics , Child , Cholestanetriol 26-Monooxygenase/genetics , Cohort Studies , Cytochrome P450 Family 2/genetics , Female , Humans , Male , Non-alcoholic Fatty Liver Disease/blood , Receptors, Calcitriol/genetics , Seasons , Vitamin D/blood
14.
Chemosphere ; 196: 115-119, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29294424

ABSTRACT

This study was aimed to determine the abundance of four antibiotic resistance genes (blaTEM, ermB, qnrS and sulI), as well as bacterial community composition associated with the intestinal mucus of wild freshwater fish species collected from the Foix and La Llosa del Cavall reservoirs, which represent ecosystems with high and low anthropogenic disturbance, respectively. Water and sediments from these reservoirs were also collected and analyzed to determine the pollution level by antibiotics. The blaTEM gene was only detected in brown trout and Ebro barbel, which were collected from La Llosa del Cavall reservoir. In contrast, the sulI and qnrS genes were only detected in common carp, which were collected from the Foix reservoir. Although the ermB gene was also detected in common carp, the values were below the limit of quantification. Likewise, water and sediment samples from the Foix reservoir had higher concentrations and more classes of antibiotics than those from La Llosa del Cavall. Pyrosequencing analysis of 16S rRNA genes revealed significant differences in bacterial communities associated with the intestinal mucus of fish species. Therefore, these findings suggest that anthropogenic activities are not only increasing the pollution of aquatic environments, but also contributing to the emergence and spread of antibiotic resistance in organisms that inhabit such environments.


Subject(s)
Anti-Bacterial Agents/analysis , Bacteria/genetics , Drug Resistance, Microbial/genetics , Fishes/microbiology , beta-Lactamases/genetics , Amide Synthases/genetics , Animals , Anti-Bacterial Agents/pharmacology , Bacteria/drug effects , Bacteria/isolation & purification , Genes, Bacterial/genetics , Methyltransferases/genetics , Microbiota/genetics , RNA, Ribosomal, 16S/genetics , Rivers/chemistry , Rivers/microbiology
15.
FEBS Lett ; 591(23): 3881-3894, 2017 12.
Article in English | MEDLINE | ID: mdl-29127710

ABSTRACT

Buthionine sulfoximine (BSO) induces decreased glutathione (GSH) and trypanothione [T(SH)2 ] pools in trypanosomatids, presumably because only gamma-glutamylcysteine synthetase (γECS) is blocked. However, some BSO effects cannot be explained by exclusive γECS inhibition; therefore, its effect on the T(SH)2 metabolism pathway in Trypanosoma cruzi was re-examined. Parasites exposed to BSO did not synthesize T(SH)2 even when supplemented with cysteine or GSH, suggesting trypanothione synthetase (TryS) inhibition by BSO. Indeed, recombinant γECS and TryS, but not GSH synthetase, were inhibited by BSO and kinetics and docking analyses on a TcTryS 3D model suggested BSO binding at the GSH site. Furthermore, parasites overexpressing γECS and TryS showed ~ 50% decreased activities after BSO treatment. These results indicated that BSO is also an inhibitor of TryS.


Subject(s)
Buthionine Sulfoximine/pharmacology , Glutathione/analogs & derivatives , Spermidine/analogs & derivatives , Trypanosoma cruzi/drug effects , Trypanosoma cruzi/metabolism , Amide Synthases/antagonists & inhibitors , Amide Synthases/chemistry , Amide Synthases/genetics , Animals , Enzyme Inhibitors/pharmacology , Glutamate-Cysteine Ligase/antagonists & inhibitors , Glutamate-Cysteine Ligase/genetics , Glutathione/biosynthesis , Glutathione/metabolism , Glutathione Synthase/antagonists & inhibitors , Glutathione Synthase/genetics , Humans , Kinetics , Metabolic Networks and Pathways/drug effects , Molecular Docking Simulation , Protozoan Proteins/antagonists & inhibitors , Protozoan Proteins/chemistry , Protozoan Proteins/genetics , Recombinant Proteins/chemistry , Recombinant Proteins/genetics , Recombinant Proteins/metabolism , Spermidine/biosynthesis , Trypanosoma cruzi/genetics
16.
J Agric Food Chem ; 65(33): 7210-7216, 2017 Aug 23.
Article in English | MEDLINE | ID: mdl-28796499

ABSTRACT

Tea (Camellia sinensis) is the most widely consumed beverage aside from water. The flavor of tea is conferred by certain metabolites, especially l-theanine, in C. sinensis. To determine why more l-theanine accumulates in C. sinensis than in other plants, we compare l-theanine contents between C. sinensis and other plant species (Camellia nitidissima, Camellia japonica, Zea mays, Arabidopsis thaliana, and Solanum lycopersicum) and use a stable isotope labeling approach to elucidate its biosynthetic route. We quantify relevant intermediates and metabolites by mass spectrometry. l-Glutamic acid, a precursor of l-theanine, is present in most plants, while ethylamine, another precursor of l-theanine, specifically accumulates in Camellia species, especially C. sinensis. Most plants contain the enzyme/gene catalyzing the conversion of ethylamine and l-glutamic acid to l-theanine. After supplementation with [2H5]ethylamine, all the plants produce [2H5]l-theanine, which suggests that ethylamine availability is the reason for the difference in l-theanine accumulation between C. sinensis and other plants.


Subject(s)
Camellia sinensis/metabolism , Glutamates/biosynthesis , Amide Synthases/genetics , Amide Synthases/metabolism , Biosynthetic Pathways , Camellia sinensis/enzymology , Camellia sinensis/genetics , Glutamate-Ammonia Ligase/genetics , Glutamate-Ammonia Ligase/metabolism , Glutamic Acid/metabolism , Plant Proteins/genetics , Plant Proteins/metabolism
17.
FEBS J ; 284(15): 2425-2441, 2017 08.
Article in English | MEDLINE | ID: mdl-28618168

ABSTRACT

Streptococcus pyogenes, also known as Group A Strep (GAS), is an obligate human pathogen that is responsible for millions of infections and numerous deaths per year. Infection manifestations can range from simple, acute pharyngitis to more complex, necrotizing fasciitis. To date, most treatments for GAS infections involve the use of common antibiotics including tetracycline and clindamycin. Unfortunately, new strains have been identified that are resistant to these drugs, therefore, new targets must be identified to treat drug-resistant strains. This work is focused on the structural and functional characterization of three proteins: spNadC, spNadD, and spNadE. These enzymes are involved in the biosynthesis of nicotinamide adenine dinucleotide (NAD+ ). The structures of spNadC and spNadE were determined. SpNadC is suggested to play a role in GAS virulence, while spNadE, functions as an NAD synthetase and is considered to be a new drug target. Determination of the spNadE structure uncovered a putative, NH3 channel, which may provide insight into the mechanistic details of NH3 -dependent NAD+ synthetases in prokaryotes. ENZYMES: Quinolinate phosphoribosyltransferase: EC2.4.2.19 and NAD synthetase: EC6.3.1.5. DATABASE: Protein structures for spNadC, spNadCΔ69A , and spNadE are deposited into Protein Data Bank under the accession codes 5HUL, 5HUO & 5HUP, and 5HUH & 5HUJ, respectively.


Subject(s)
Amide Synthases/metabolism , Bacterial Proteins/metabolism , Models, Molecular , Nicotinamide-Nucleotide Adenylyltransferase/metabolism , Pentosyltransferases/metabolism , Quinolinic Acid/metabolism , Streptococcus pyogenes/metabolism , Adenosine Triphosphate/chemistry , Adenosine Triphosphate/metabolism , Amide Synthases/chemistry , Amide Synthases/genetics , Apoenzymes/chemistry , Apoenzymes/genetics , Apoenzymes/metabolism , Bacterial Proteins/chemistry , Bacterial Proteins/genetics , Binding Sites , Catalytic Domain , Cluster Analysis , Computational Biology , Crystallography, X-Ray , Dimerization , Gene Deletion , Nicotinamide-Nucleotide Adenylyltransferase/chemistry , Nicotinamide-Nucleotide Adenylyltransferase/genetics , Pentosyltransferases/chemistry , Pentosyltransferases/genetics , Protein Conformation , Protein Interaction Domains and Motifs , Protein Multimerization , Protein Structure, Quaternary , Recombinant Proteins/chemistry , Recombinant Proteins/metabolism , Structural Homology, Protein
18.
Curr Opin Genet Dev ; 44: 156-162, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28445802

ABSTRACT

Nicotinamide mononucleotide adenylyl transferases (NMNATs) are a family of highly conserved proteins indispensable for cellular homeostasis. NMNATs are classically known for their enzymatic function of catalyzing NAD+ synthesis, but also have gained a reputation as essential neuronal maintenance factors. NMNAT deficiency has been associated with various human diseases with pronounced consequences on neural tissues, underscoring the importance of the neuronal maintenance and protective roles of these proteins. New mechanistic studies have challenged the role of NMNAT-catalyzed NAD+ production in delaying Wallerian degeneration and have specified new mechanisms of NMNAT's chaperone function critical for neuronal health. Progress in understanding the regulation of NMNAT has uncovered a neuronal stress response with great therapeutic promise for treating various neurodegenerative conditions.


Subject(s)
Molecular Chaperones/genetics , Neurodegenerative Diseases/genetics , Neurons/enzymology , Nicotinamide-Nucleotide Adenylyltransferase/genetics , Amide Synthases/genetics , Humans , NAD/biosynthesis , Neurodegenerative Diseases/enzymology , Neurodegenerative Diseases/pathology , Neurons/pathology
19.
Metab Eng ; 33: 98-108, 2016 Jan.
Article in English | MEDLINE | ID: mdl-26617065

ABSTRACT

Long-chain polyunsaturated fatty acids (LC-PUFAs) can be produced de novo via polyketide synthase-like enzymes known as PUFA synthases, which are encoded by pfa biosynthetic gene clusters originally discovered from marine microorganisms. Recently similar gene clusters were detected and characterized in terrestrial myxobacteria revealing several striking differences. As the identified myxobacterial producers are difficult to handle genetically and grow very slowly we aimed to establish heterologous expression platforms for myxobacterial PUFA synthases. Here we report the heterologous expression of the pfa gene cluster from Aetherobacter fasciculatus (SBSr002) in the phylogenetically distant model host bacteria Escherichia coli and Pseudomonas putida. The latter host turned out to be the more promising PUFA producer revealing higher production rates of n-6 docosapentaenoic acid (DPA) and docosahexaenoic acid (DHA). After several rounds of genetic engineering of expression plasmids combined with metabolic engineering of P. putida, DHA production yields were eventually increased more than threefold. Additionally, we applied synthetic biology approaches to redesign and construct artificial versions of the A. fasciculatus pfa gene cluster, which to the best of our knowledge represents the first example of a polyketide-like biosynthetic gene cluster modulated and synthesized for P. putida. Combination with the engineering efforts described above led to a further increase in LC-PUFA production yields. The established production platform based on synthetic DNA now sets the stage for flexible engineering of the complex PUFA synthase.


Subject(s)
Amide Synthases/metabolism , Docosahexaenoic Acids/biosynthesis , Fatty Acids, Unsaturated/metabolism , Metabolic Engineering/methods , Myxococcales/enzymology , Pseudomonas putida/enzymology , Amide Synthases/genetics , Cloning, Molecular/methods , Docosahexaenoic Acids/genetics , Docosahexaenoic Acids/isolation & purification , Fatty Acids, Unsaturated/genetics , Myxococcales/genetics , Pseudomonas putida/genetics , Recombinant Proteins/metabolism
20.
Mol Biochem Parasitol ; 206(1-2): 67-74, 2016.
Article in English | MEDLINE | ID: mdl-26592324

ABSTRACT

Trypanosomatids are the causative agents of African sleeping sickness, Chagas' disease, and the different forms of leishmaniasis. This family of protozoan parasite possesses a trypanothione-based redox metabolism that provides the reducing equivalents for various vital processes such as the biosynthesis of DNA precursors and the detoxification of hydroperoxides. Almost all enzymes of the redox pathway proved to be essential and therefore fulfil one crucial prerequisite for a putative drug target. Trypanothione synthetase and trypanothione reductase are present in all trypanosomatids but absent from the mammalian host which, in addition to the essentiality, renders them highly specific. The chemotherapy research on both enzymes is further supported by the availability of high-throughput screening techniques and crystal structures. In this review we focus on the recent advances and limitations in the development of lead compounds targeting trypanothione synthetase and trypanothione reductase. We present an overview of the available inhibitors and discuss future perspectives including other components of the parasite-specific redox pathway.


Subject(s)
Amide Synthases/antagonists & inhibitors , Antiprotozoal Agents/pharmacology , Enzyme Inhibitors/pharmacology , NADH, NADPH Oxidoreductases/antagonists & inhibitors , Protozoan Proteins/antagonists & inhibitors , Amide Synthases/genetics , Amide Synthases/metabolism , Animals , Antiprotozoal Agents/chemical synthesis , Chagas Disease/drug therapy , Chagas Disease/parasitology , Enzyme Inhibitors/chemical synthesis , Gene Expression , High-Throughput Screening Assays , Leishmania/drug effects , Leishmania/enzymology , Leishmania/genetics , Leishmania/growth & development , Leishmaniasis/drug therapy , Leishmaniasis/parasitology , Molecular Targeted Therapy , NADH, NADPH Oxidoreductases/genetics , NADH, NADPH Oxidoreductases/metabolism , Oxidation-Reduction , Protozoan Proteins/genetics , Protozoan Proteins/metabolism , Structure-Activity Relationship , Sulfhydryl Compounds/metabolism , Trypanosoma/drug effects , Trypanosoma/enzymology , Trypanosoma/genetics , Trypanosoma/growth & development , Trypanosomiasis, African/drug therapy , Trypanosomiasis, African/parasitology
SELECTION OF CITATIONS
SEARCH DETAIL